Literature DB >> 10625868

Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene.

T Walther1, N Wessel, N Kang, A Sander, C Tschöpe, H Malberg, M Bader, A Voss.   

Abstract

Heart rate variability is a relevant predictor of cardiovascular risk in humans. A significant genetic influence on heart rate variability is suggested, although the genes involved are ill-defined. The Mas-protooncogene encodes a G-protein-coupled receptor with seven transmembrane domains highly expressed in testis and brain. Since this receptor is supposed to interact with the signaling of angiotensin II, which is an important regulator of cardiovascular homeostasis, heart rate and blood pressure were analyzed in Mas-deficient mice. Using a femoral catheter the blood pressure of mice was measured for a period of 30 min and 250 data values per second were recorded. The mean values and range of heart rate and blood pressure were then calculated. Neither heart rate nor blood pressure were significantly different between knockout mice and controls. However, high resolution recording of these parameters and analysis of the data by non-linear dynamics revealed significant alterations in cardiovascular variability in Mas-deficient animals. In particular, females showed a strong reduction of heart rate variability. Furthermore, the data showed an increased sympathetic tone in knockout animals of both genders. The marked alterations detected in Mas-deficient mice of both genders suggest that the Mas-protooncogene is an important determinant of heart rate and blood pressure variability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625868     DOI: 10.1590/s0100-879x2000000100001

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  14 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

3.  Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice.

Authors:  Yu Wang; Robin Shoemaker; David Powell; Wen Su; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-16       Impact factor: 4.733

Review 4.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

5.  Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.

Authors:  Robson A S Santos; Ana C Simoes e Silva; Christine Maric; Denise M R Silva; Raquel Pillar Machado; Insa de Buhr; Silvia Heringer-Walther; Sergio Veloso B Pinheiro; Myriam Teresa Lopes; Michael Bader; Elizabeth P Mendes; Virgina Soares Lemos; Maria Jose Campagnole-Santos; Heinz-Peter Schultheiss; Robert Speth; Thomas Walther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

Review 6.  Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.

Authors:  Anderson J Ferreira; Robson A S Santos; Chastity N Bradford; Adam P Mecca; Colin Sumners; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

7.  Cognitive benefits of angiotensin IV and angiotensin-(1-7): A systematic review of experimental studies.

Authors:  Jean K Ho; Daniel A Nation
Journal:  Neurosci Biobehav Rev       Date:  2018-05-04       Impact factor: 8.989

8.  Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors.

Authors:  Megumi Kanasaki; Takako Nagai; Munehiro Kitada; Daisuke Koya; Keizo Kanasaki
Journal:  Fibrogenesis Tissue Repair       Date:  2011-11-30

9.  Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation.

Authors:  Vanesa Esteban; Silvia Heringer-Walther; Anja Sterner-Kock; Ron de Bruin; Sandra van den Engel; Yong Wang; Sergio Mezzano; Jesus Egido; Heinz-Peter Schultheiss; Marta Ruiz-Ortega; Thomas Walther
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

Review 10.  New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.

Authors:  Jia L Zhuo; Fernanda M Ferrao; Yun Zheng; Xiao C Li
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.